No Data
Daily futures tracking | Chip stocks have rebounded over the past few days, Nvidia and Broadcom single trading are active; gold and silver spot has soared, and related ETF bullish options have earned nearly 20 times overnight
Are bears sniping at Intel? The bearish ratio rose to 72%, and put trading volume increased dramatically; Broadcom rose by 3.97% to lead the rise in star technology stocks, and earned 6 times the profit from a single call due in October.
Mizuho Securities Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating
Mizuho Securities analyst Graig Suvannavejh maintains $Corbus Pharmaceuticals(CRBP.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 43.5% and a total average
Buy Rating Affirmed for Corbus Pharmaceuticals Amid Promising Outlook for Novel Oral Weight Loss Therapy CRBP-913
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
Airpod Pro To Have Clinical Grade Over The Counter Hearing Aid Feature
Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference